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ORIGINAL ARTICLE
Seasonal variation of serotonin turnover in human cerebrospinal
fluid, depressive symptoms and the role of the 5-HTTLPR
JJ Luykx1,2, SC Bakker1, N van Geloven3, MJC Eijkemans4, S Horvath5,6, E Lentjes7, MPM Boks1, E Strengman8, J DeYoung9,
JE Buizer-Voskamp1, RM Cantor6, A Lu6, EPA van Dongen10, P Borgdorff11, P Bruins10, RS Kahn1 and RA Ophoff1,5,9
Studying monoaminergic seasonality is likely to improve our understanding of neurobiological mechanisms underlying
season-associated physiological and pathophysiological behavior. Studies of monoaminergic seasonality and the influence of the
serotonin-transporter-linked polymorphic region (5-HTTLPR) on serotonin seasonality have yielded conflicting results, possibly
due to lack of power and absence of multi-year analyses. We aimed to assess the extent of seasonal monoamine turnover and
examined the possible involvement of the 5-HTTLPR. To determine the influence of seasonality on monoamine turnover,
5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were measured in the cerebrospinal fluid of 479 human subjects
collected during a 3-year period. Cosine and non-parametric seasonal modeling were applied to both metabolites. We
computed serotonin (5-HT) seasonality values and performed an association analysis with the s/l alleles of the 5-HTTLPR. Depressive
symptomatology was assessed using the Beck Depression Inventory-II. Circannual variation in 5-HIAA fitted a spring-peak
cosine model that was significantly associated with sampling month (P¼ 0.0074). Season of sampling explained 5.4%
(P¼ 1.57 10 7) of the variance in 5-HIAA concentrations. The 5-HTTLPR s-allele was associated with increased 5-HIAA seasonality
(standardized regression coefficient¼ 0.12, P¼ 0.020, N¼ 393). 5-HIAA seasonality correlated with depressive symptoms
(Spearman’s rho¼ 0.13, P¼ 0.018, N¼ 345). In conclusion, we highlight a dose-dependent association of the 5-HTTLPR with
5-HIAA seasonality and a positive correlation between 5-HIAA seasonality and depressive symptomatology. The presented
data set the stage for follow-up in clinical populations with a role for seasonality, such as affective disorders.
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INTRODUCTION
Seasonal variation in monoaminergic transmission may be one of
the mechanisms explaining circannual fluctuations in behavior,
which range from suicide in humans1–4 to mating in animals.5,6
The monoamines dopamine (DA) and serotonin (5-HT) have
pivotal roles in human behavior. 5-HT regulates a plethora of
behavioral, cognitive and physiological functions, such as mood,
aggression, reward, sexuality, attention, memory and
perception;7,8 DA mediates a similarly diverse list of neuroen-
docrine, behavioral and neurophysiological actions.9 Although
preliminary evidence indicates that monoaminergic transmission
in human cerebrospinal fluid (CSF) varies between seasons, the
results of such studies are inconsistent.10–13 Limited sample sizes
and absence of multi-year analyses constitute the foremost
explanations behind such discrepancies. Insufficient power of
these investigations further precludes reliable estimations of the
explained variances in monoamine transmission by seasonal
factors. As a consequence, it has not been unequivocally
determined whether and to what degree seasonal factors
explain variation in monoaminergic transmission.
Studying monoaminergic seasonality is likely to improve our
understanding of neurobiological mechanisms underlying season-
associated physiological and pathophysiological behavior, such as
suicide and seasonal affective disorder (SAD). Although the
heritability (h2) of seasonality in monoamine turnover is unknown,
twin studies indicate that seasonal fluctuations in human behavior
(for example, sleep and mood) are highly heritable, particularly in
men (h2¼ 69%).14,15 The genotype most extensively investigated
for its role in monoaminergic seasonality is the s/l (short/long)
polymorphism of the 5-HT transporter-linked polymorphic
region (5-HTTLPR). By measuring internal jugular venoarterial
5-hydroxyindoleacetic acid (5-HIAA), the minor s-allele of this
genotype was found to be associated with a more than twofold
greater brain 5-HT turnover rate than the major allele.16 Notably,
seasonality in 5-HT transporter (5-HTT) binding measured with
positron emission tomography (PET) in the putamen is also
associated with the s-allele of the 5-HTTLPR.17 Furthermore, other
lines of evidence hint at an impact of this polymorphism on a
variety of 5-HT seasonality measures in humans, including 5-HT
concentrations in blood, seasonal behavior and 5-HTT binding
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measured with PET and single-photon emission computed tomo-
graphy.18–22 However, these studies investigating the influence of
the 5- HTTLPR on measures of 5-HT seasonality are inconsistent with
regard to seasonal directionality, that is, whether the s-allele
increases or diminishes 5-HT seasonality. Such incongruities may
have originated from the small and diverse study populations they
were based on.17–21 A well-powered genetic study targeting 5-HT
seasonality in a homogeneous sample of subjects has the potential
to resolve these inconsistencies. In addition, unraveling the
seasonality of monoamine turnover and clarifying the impact of
the 5-HTTLPR on 5-HT seasonality may open avenues for clinical
research. For example, 5-HTT aberrations have been detected in
SAD23 and comparisons of seasonal patterns in (5-HTTLPR mediated)
5-HT turnover between SAD cases and controls may aid in the
elucidation of the unknown pathophysiology of this disorder.
Based on a recent study by our group,12 we reasoned that
season of sampling and season of birth influence 5-HIAA but not
homovanillic acid (HVA) concentrations in human CSF. To
unambiguously assess the association of such seasonal factors
with monoamine turnover, CSF measurements were carried out in
479 individuals over three consecutive years. Given the influence
of 5-HTTLPR s-allele carrier status on seasonality in 5-HTT
binding,17 we hypothesized that a relatively large sample size
would allow us to detect dose-dependent effects of the 5-HTTLPR
on seasonality of 5-HT turnover (here defined as CSF 5-HIAA
concentrations). We accordingly aimed to clarify whether this
polymorphism predicts seasonal variation in 5-HIAA levels in
human CSF. To that end, we first computed per-subject 5-HIAA
seasonality values and subsequently analyzed the association of
these values with the 5-HTTLPR s/l polymorphism. Finally, to
extend the findings to the behavioral level, we correlated 5-HIAA
seasonality with depressive symptomatology.
MATERIALS AND METHODS
Subjects
Subject collection procedures have been described elsewhere.12 In brief,
479 volunteers were recruited at outpatient preoperative screening
services in four hospitals in and around Utrecht, The Netherlands, from
28 August 2008 until 31 August 2011. The ethics committee at the
University Medical Center Utrecht (UMCU) and all local ethics committees
approved this study. Written informed consent was obtained from the
participants. Seasonal variation in monoaminergic transmission was also
analyzed in a subset of the study population in a previous study (N¼ 223,
that is, 47% of the study population).12 We included patients (i)
undergoing spinal anesthesia for minor elective surgical procedures; (ii)
ranging between 18–60 years of age; and (iii) with four grandparents born
in The Netherlands or other North-Western European countries (Belgium,
Germany, the United Kingdom, France and Denmark). Each candidate
participant received a personal telephone interview to exclude subjects
with a self-reported history of psychotic or major neurological disorders
(stroke, brain tumors and neurodegenerative diseases) and to record any
use of psychotropic medication. A self-reported history of non-psychotic
unipolar affective, attention-deficit-hyperactivity and anxiety disorders was
allowed and recorded if applicable.
Collection of CSF, DNA and 5-HIAA measurements
These methods have been described elsewhere.12 In brief, a single
sample of 6ml of CSF was suctioned from each (sitting) participant and
transported the same day to the laboratory, where fractions of 0.5 and 1ml
were immediately stored at  80 1C. Concentrations of 5-HIAA and HVA in
CSF were measured using high-performance liquid chromatography, as
described previously.12 A whole-blood sample was used to extract
genomic DNA using standard techniques in a subset of the study
population (N¼ 414).
Genotyping procedures
As part of an on-going project, genotype data of 414 subjects were
collected using the Illumina HumanOmniExpress Beadchip at the UCLA
Neurosciences Genomics Core (UNGC). Quality control was conducted as
described in the Supplementary Methods, leaving 398 individuals. We used
a recently developed machine-learning method of vertex discriminant
analysis validated for Northern European populations to predict the
5-HTTLPR polymorphism.24 In brief, this genotype prediction method
prognosticates the 5-HTTLPR genotype based on eight single-nucleotide
polymorphisms (SNPs). Three of the eight SNPs had been imputed, as
described in the Supplementary Methods. Imputation r2 values for these
three SNPs were 1.00 (rs1487971; rs7217677) and 0.94 (rs887469). All eight
SNPs passed the quality control thresholds outlined in the Supplementary
Methods (o2% genotyping missingness, Hardy–Weinberg equilibrium
P41 10 6, and minor allele frequency 40.05).
Seasonal modeling
Collinearity between sampling and birth dates was not detected (Spear-
man’s rho¼ 0.03, P¼ 0.5). To test the association of season of sampling
and season of birth with 5-HIAA concentrations, nonlinear quantile
regression (nlqr)—modeling seasonal variation in the median 5-HIAA
values per month assuming a nonlinear cosine-shaped relationship—was
chosen before inspecting circannual metabolite concentration
variability.12 To validate the cosine function and model concentrations
per day non-parametrically, LOESS (locally weighted scatterplot
smoothing, span¼ 0.75) was employed.12 Given the highly significant
previous seasonal findings, we reasoned that a twice as large study
population would provide sufficient power to detect seasonal
fluctuations.12 The same covariates as in a previous study on mono-
amine metabolite seasonality were incorporated, that is, age and sex for
5-HIAA and weight and lumbar interspace level (L3-L4 vs L4-L5 vs L5-S1) in
addition to these two for HVA (also see this reference for all candidate
covariates tested, for example, time of day of sampling and psychotropic
medication).12 Nlqr models were fitted for a one- and two-peak scenario as
outlined in the Supplementary Methods. The best fitting model of these
two scenarios (defined as the one showing less deviance) was chosen per
metabolite. The nlqr significance level was Bonferroni corrected (a¼ 0.05/
4¼ 0.0125 as both season of sampling and season of birth effects were
tested for 5-HIAA and HVA). Whenever 3 months with highest median
metabolite concentrations were sequential, the Kruskal–Wallis (K–W) test
was used to compare metabolite levels between that season and the other
seasons taken together (a¼ 0.05). Although duration of bright sunlight
has been associated with the rate of 5-HT production,13 our data (Results
section) were not compatible with a correlation between sunlight
exposure and 5-HIAA as these concentrations were highest in mid
spring, whereas rapidly dropping in summer. We therefore did not
investigate sunlight exposure effects on 5-HIAA concentrations in CSF. We
then computed the explained variance in metabolite concentration by
season using analysis of covariance, setting metabolite concentrations
as dependent variables; sampling or birth season (dichotomized: three
consecutive peak months vs all other months of the year) as independent
variables; and incorporating age and sex as covariates. The sum of squares
for seasonal effect was then divided by the total sum of squares (a¼ 0.05).
These analyses were performed with the statistical software packages SPSS
(IBM SPSS Statistics for Mac, Version 20.0, Armonk, NY, USA) and RStudio
(www.rstudio.com).
Computation of 5-HIAA seasonality values and association testing
of the 5-HTTLPR
To assess the genetic association with 5-HIAA seasonality, we first
calculated 5-HIAA seasonality values for the entire study population. We
define 5-HIAA seasonality as the degree to which CSF 5-HIAA levels vary by
season of sampling, that is, the difference between the observed 5-HIAA
value and the 5-HIAA value predicted by the best fitting nlqr cosine model.
Measured 5-HIAA values above the cosine during the 6 months
surrounding the peak of the cosine (here: January–June) and values below
the cosine during the rest of the year were defined as positively seasonal,
whereas all other values were deemed negatively seasonal. In other words,
positive 5-HIAA seasonality values correspond to larger predicted
amplitudes than negative values (see Figure 1a for a graph of the
measured values and their direction of seasonality). In the Supplementary
Methods, we give examples of how observed 5-HIAA values translate into
seasonality values and of the 5-HIAA values and numbers of subjects per
sampling month.
Genotype summary statistics were generated in Plink V1.07.25 To test for
the association between the 5-HTTLPR s/l polymorphism and the 5-HIAA
seasonality, a linear additive model was run in Plink V1.07.25 The same
linear model was applied to Beck Depression Inventory II (BDI-II) scores to
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rule out direct effects of this genotype on depressive symptomatology. As
age and sex were included in the model used for computation of 5-HIAA
seasonality values, we provide the following association statistics for linear
models with and without these covariates (a¼ 0.05): standardized
regression coefficients (b) that correspond to a change in 5-HIAA
seasonality by an increase in the number of s-alleles, that is, from 0 to 1
to 2; and P-values. As a test of robustness, we repeated the analysis on a
subset of patients resulting from excluding subjects currently on
psychotropic medication or with a self-reported psychiatric history. To
rule out direct associations of the 5-HTTLPR with CSF 5-HIAA, the
association of the 5-HTTLPR s/l polymorphism with absolute
concentrations of CSF 5-HIAA was tested.
Assessment of depressive symptoms and correlation analysis with
5-HIAA seasonality
Affective disorders (SAD and bipolar II disorder, in particular) are most
commonly associated with seasonal behavioral fluctuations.26 We
therefore assessed the association of seasonal variation in 5-HT
transmission with depressive symptomatology as a quantitative trait.
To that end, all participants were asked to fill out the Dutch version of the
BDI-II27 online within 2 weeks after their surgical elective procedure. We
chose web-based symptom questionnaires as these have been validated as
reliable assessment tools in a range of epidemiological studies28,29 and
may decrease socially desirable responses compared to face-to-face
interviews or questionnaires that are filled out in clinical settings.30,31 To
test whether depressive symptoms show seasonal variation, we applied
the best fitting of models 1a and b (Supplementary Methods) to BDI-II
scores. We then used the non-parametric Spearman’s correlation test to
estimate the possible correlation between 5-HIAA seasonality values and
BDI-II total scores (a¼ 0.05), as total BDI-II scores were not normally
distributed (K–S two-tailed Po0.001, Supplementary Methods). To rule out
direct associations between absolute 5-HIAA values and BDI-II scores,
correlations between the CSF 5-HIAA and BDI-II scores were also estimated
using Spearman’s correlation.
RESULTS
Descriptive statistics
The study population consisted of 479 subjects, of whom 71%
were male (Table 1). The mean (s.d.) concentrations of 5-HIAA and
HVA were 169 (68.6) and 217 (75.1) nmol l 1, respectively
(Supplementary Figure 1). Twenty-three subjects (4.8%) had a
self-reported history of psychiatric illness and 13 (2.7%) were on
psychotropic medication during the lumbar puncture.
Monoamine metabolite seasonality
(Figures 1 and 2) For 5-HIAA, the one-peak nlqr-model sampling
model showed less deviance than the two-peak model
(Supplementary Methods) and was significant (P of the amplitude
of the cosine¼ 0.0074, Figure 1b). The LOESS followed a similar
pattern to the cosine, validating the chosen model (Figure 1b).
Figure 1a provides the raw 5-HIAA measurements per subject and
sampling month. Peak and trough concentrations were in late
March (tmax¼ 3.8) and September (tmin¼ 9.8), respectively. Con-
centrations were 44% increased in spring compared with the
other months. In the Supplementary Methods, summary statistics
per nlqr-model are given. Three consecutive spring months
Figure 1. (a). Graph displaying measured 5-HIAA data points per sampling month and 5-HIAA seasonality values (N¼ 479). Measured 5-HIAA
concentrations (nmol l 1) per subject are plotted against sampling month. Positively seasonal values are green and negatively seasonal values
red. The covariates age and sex are included in the model, explaining why some values in January–June are green when under and red when
above the cosine curve (and vice versa for July–December). Red line represents the cosine; black line the LOESS; dashed line the 95%
confidence intervals (CIs) of the cosine; and whiskers 95% CIs of median CSF 5-HIAA concentrations per sample month. (b) Median CSF 5-HAA
concentrations (in nmol l 1) are plotted against month of CSF sampling (N¼ 479). Bold line represents cosine, thin line represents LOESS and
dashed lines represent 95% CIs of the cosine. Whiskers indicate 95% CIs of median CSF 5-HIAA concentrations.
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(March, April and May) showed highest mean and median 5-HIAA
levels and differed from the other months considered together:
the mean (s.d.) 5-HIAA concentration in these three months was
195 (73.1), whereas in the other months the mean was 158 (64.1)
nmol l 1 (K–W test P¼ 6.4 10 7, Figure 2). The explained
variance in 5-HIAA concentrations by sampling in these three
months was 5.4% (P¼ 1.57 10 7). The 5-HIAA season of birth
results were nonsignificant.
For HVA, no significant associations with sampling month or
birth month were found (Supplementary Methods).
Association of the 5-HTTLPR genotype with 5-HIAA seasonality
(Figure 3) After genotype quality control (Supplementary
Methods), 398 subjects remained, for 393 from whom 5-HIAA
levels were available. The genotypes were in Hardy–Weinberg
equilibrium (P40.5) and the numbers of subjects per genotype
were: 73 (19%) S/S, 192 (49%) S/L and 128 (33%) L/L. The mean
(s.e.) 5-HIAA seasonality values per genotype were: 11.39 (7.61),
0.13 (4.96) and  10.22 (5.41), respectively (Figure 3). A dose-
dependent positive association of the s-allele with 5-HIAA
seasonality was detected in the models with and without
covariates age and sex (b¼ 0.12, P¼ 0.020; and b¼ 0.11,
P¼ 0.023, respectively). When excluding subjects on psychotropic
mediation or with a self-reported psychiatric history, the results
did not change (b¼ 0.12, P¼ 0.019). Neither absolute concentra-
tions of CSF 5-HIAA nor BDI-II scores were associated with the
5-HTTLPR (P¼ 0.2 and 0.8, respectively).
Correlation between 5-HIAA seasonality and depressive symptoms
Four hundred and six (85%) of the 479 subjects filled out the BDI-II;
the mean total score (s.d.) was 4.48 (5.32). For 345 subjects, both
5-HIAA seasonality values and BDI-II scores were available. No
seasonal patterns in mood symptoms were detected (Supplementary
Methods). 5-HIAA seasonality correlated positively with total BDI-II
scores (Spearman’s rho¼ 0.13, P¼ 0.018), whereas CSF 5-HIAA did
not correlate with BDI-II scores (Spearman’s rho¼ 0.04, P¼ 0.45).
DISCUSSION
In this 3-year study of CSF monoamine turnover (N¼ 479), we
confirm that 5-HIAA concentrations fit a cosine model that
displays a peak in spring and a trough in fall. We additionally
show that a significant proportion of the variance (5.4%) in
5-HIAA concentrations is explained by seasonality. Furthermore,
we demonstrate a dose-dependent association of the 5-HTTLPR
s-allele with seasonality of 5-HT turnover, whereas this
polymorphism was not associated with absolute 5-HIAA levels.
Finally, 5-HIAA seasonality correlated positively with depressive
symptoms.
The current data are based on the largest number of years and
participants in seasonal research of CSF monoaminergic transmis-
sion in humans or non-human primates to date. Multi-year
sampling offers the advantage of curtailing the type-I error
likelihood (in this context referring to stochastic seasonal patterns
either due to chance or unique factors influencing CSF 5-HIAA in a
particular season or year). Our design has thus enabled us to
clarify some of the issues related to the much-debated and
inconsistent findings in seasonal research of CSF monoaminergic
transmission.5,6,10–12,32,33 The CSF 5-HIAA peak in spring that we
detected is in agreement with a previous study (for which part of
the current study population was used).12 The 5-HIAA increases
from trough to peak and the summary statistics of the non-
quantile regression were similar to those previous findings.
Although season of birth and 5-HIAA fitted a cosine model in
that study,12 the exceptionally high September concentrations
constituted a limitation. The current sample size, which is more
than twice the previous one and collected over almost a twofold
longer period, allows for more reliable conclusions and thus
makes it unlikely that 5-HIAA in human CSF is influenced by
season of birth. The lack of HVA seasonality findings is in
agreement with the previous study.12
We furthermore demonstrate that seasonality explains over 5%
of the variation in CSF 5-HIAA, which is substantial for a biological
trait. Previously discussed explanations behind explained variance
in 5-HIAA by season may be divided into conception-related and
melatonin metabolism-dependent.12 In brief, from an evolutionary
perspective and given the association of CSF 5-HIAA with
reproductive behavior,5,6 increased 5-HT availability in spring
Table 1. Descriptive statistics of the study population (N¼ 479); part
of whom were genotyped (N¼ 414)
Mean/N (%) s.d.
5-HIAA (nmol l 1) 169 68.64
HVA (nmol l 1) 217 75.07
N male 340 (71) N/A
Age (years) 40 11.3
Spring sampling (21 March—20 June) 134 (28) N/A
Psychiatric history 23 (4.8) N/A
Psychotropic medication 13 (2.7) N/A
Knee arthroscopiesa 354 (74%) N/A
aOther procedures (all approximately equally frequent) included other
orthopedic surgeries (for example, excess bone removal and hallux vagus
corrections), inguinal hernia operations (mostly Lichtenstein repair) and
chronic venous insufficiency treatments.
Figure 2. Kruskal–Wallis test results for CSF 5-HAA (± s.e.) in the
three consecutive months with highest 5-HIAA concentrations
(March–May¼ 1) vs the other months of the year (¼ 0).
Figure 3. Mean 5-HIAA seasonality values (± s.e.) are shown per
5-HTTLPR genotype: S/S (N¼ 73): 11.39±7.61. S/L (N¼ 192):
0.13±4.96. L/L (N¼ 128):  10.22±5.41.
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may have driven up spring birth rates and thereby advanced
survival until recently in human history. Alternatively, because
5-HT is the precursor of melatonin, metabolism pathways of these
two molecules are likely to be interdependent. Melatonin is a
seasonal zeitgeber for reproduction and higher basal melatonin
concentrations have been demonstrated in fall than in spring
across a range of species.34,35 A CSF 5-HIAA spring peak could
therefore be consequential to seasonal shifts in melatonin
metabolism. A final explanation behind increased 5-HIAA in
spring not previously discussed relates to 5-HTT availability. As
demonstrated by single-photon emission computed tomography
imaging techniques,21 5-HTT availability rises in winter. Possibly,
upregulated 5-HTT facilitates reuptake of 5-HT and thereby
prevents its breakdown in winter, whereas 5-HT breakdown into
5-HIAA may increase when more 5-HTT is available in spring.
The genetic findings imply that in our study population
5-HTTLPR s-allele homozygous subjects are positively seasonal
(that is, tend to have relatively high CSF 5-HIAA in spring or low
5-HIAA in fall), whereas heterozygotes follow the expected cosine
circannual pattern (that is, their mean seasonality value isB0) and
L-homozygotes are negatively seasonal (that is, show a flattened
seasonal curve). By demonstrating a dose-dependent association
of the 5-HTTLPR s-allele with seasonal variation in 5-HIAA, we
extend the results of a PET study comparing s-allele carriers to
l-homozygous subjects.17 Our finding is furthermore consistent
with a meta-analysis that detected less-frequent s-allele genotype
frequencies in subjects with low seasonal variation in affective
symptoms.22 Finally, the previously signaled seasonal variation in
5-HTT binding measured by PET in s-allele carriers17 appears in
phase with the CSF 5-HIAA spring peak presented here that in turn
is heightened in s-allele homozygous subjects. That this 5-HIAA
peak comes one season after the increase in 5-HTT binding is in
keeping with the abovementioned hypothesis about the impact of
5-HTT availability on CSF 5-HIAA. To our knowledge, no genetic
study on CSF 5-HIAA seasonality in healthy subjects had been
reported. In addition, the approaches adopted by all but one
group17 investigating seasonality of 5-HT measures entailed
dividing the year into four seasons, as opposed to per-month
modeling of 5-HT seasonality. Moreover, in contrast to the
previous studies on 5-HT seasonality,17–19,21 the current sample
size (N¼ 414) yields adequate genotype distributions to analyze
5-HTTLPR dose-dependent associations with 5-HIAA seasonality.
Our observation of the positive correlation between 5-HIAA
seasonality and depressive symptomatology suggests that not
absolute 5-HIAA concentrations but seasonal patterns in 5-HT
turnover variability could influence susceptibility to depressive
symptomatology. Such a contention would be in line with
epidemiological evidence pointing to a latitude-dependent
seasonal variation in suicide rates, that is, spring peaks in high-
latitude regions and absence of seasonal variation around the
equator.36–38 Speculatively, seasonal variation in CSF 5-HIAA may
be more pronounced at higher latitudes, which in turn would
confer risk for season-associated depression, and thereby suicide.
Furthermore, meta-analytical evidence indicates that monoamine
depletion does not diminish mood in healthy subjects,39 pleading
against direct causal effects of 5-HIAA concentrations in depres-
sive symptomatology.
A limitation of this study is that psychiatric illness was not
systematically assessed. However, running the same nlqr models
after excluding the subjects on psychotropic medication during
the lumbar puncture (N¼ 13) and those with a self-reported
history of psychiatric illness (N¼ 23) did not change the CSF
5-HIAA seasonality findings (Supplementary Figures 2A and 2B,
summary statistics not shown). A second potential caveat is that
the 5-HTTLPR prediction model that we applied24 explains 85% of
the variation in the 5-HTTLPR, although this figure exceeds the R2
of a different SNP-based 5-HTTLPR prediction model.40 Notably,
there is no ‘gold standard’ for 5-HTTLPR genotyping and direct
genotyping is notoriously cumbersome.24 Moreover, the genotype
distributions reported here are identical to previously reported
distributions in Dutch healthy individuals.24 Regarding the
correlation between 5-HIAA seasonality and BDI-II symptoms,
the sample size (N¼ 345) and Spearman’s rank correlation
coefficient (r¼ 0.13) were relatively small. We also recognize that
the absences of an independent replication cohort and repeated
measurements—both of which are due to intricacies inherent in
human CSF collection—constitute constraints. Finally, although
subjects had fasted at least 6 h before the lumbar puncture, we
cannot correct for dietary factors as such data were unavailable for
the current study.
Our findings contribute to unmasking the molecular basis of
seasonality of 5-HT turnover and the potential role of the
5-HTTLPR. Larger sample sizes or within-subject designs are
needed to replicate our findings and further investigate the
genetic basis of 5-HT seasonality. Targeted studies, such as PET,
could be performed to examine the role of MAO-A,41–43 a major
enzyme in the 5-HT pathway. MAO-A PET has demonstrated
relevance for studying psychiatric phenotypes.41–43 Future studies
should involve sampling around the equator as well as at different
latitudes in the Northern and Southern hemispheres to gain a
better understanding of how 5-HT turnover in CSF varies between
seasons and around the globe. Moreover, such a study would
provide the means to investigate the latitude-dependent role of
the 5-HTTLPR and other genetic factors in 5-HIAA seasonality and
possible relationships with neurobehavioral traits (such as SAD,
bipolar disorder and suicide). When complemented with
assessments of additional 5-HT-associated phenotypes (for
example, 5-HTT binding measured with PET, platelet 5-HT
uptake, platelet 5-HT content, and plasma tryptophan and
melatonin levels44), such projects may comprehensively dissect
the genetic determinants of 5-HT physiology. This in turn may
open avenues for applications in clinical populations with an
established role for seasonality, such as affective disorders.
In summary, we highlight a dose-dependent association of the
5-HTTLPR s/l polymorphism with 5-HIAA seasonality and demon-
strate that increased 5-HIAA seasonality is associated with
depressive symptomatology. Notably, 5-HIAA seasonal variability
and not absolute 5-HIAA concentrations show associations with
genetic background and mood symptoms, underscoring the
biological relevance of 5-HT seasonality.
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